HELP (Helus Pharma) Pretax Margin %: % (As of Dec. 2025)


HELP Helus Pharma Inc HELP
22 GF Score
Price $6.88
! 1 Warning Sign
View Full Analysis

What is Helus Pharma Pretax Margin %?

Helus Pharma HELP +6.17% 22 Pretax Margin % is % as of Dec. 2025. GuruFocus rates HELP with a GF Score™ of 22/100. The stock has 1 warning sign investors should review. Among 944 Biotechnology companies, Helus Pharma ranks worse than 105932.1% on this metric.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Helus Pharma's Pre-Tax Income for the three months ended in Dec. 2025 was $-42.67 Mil. Helus Pharma's Revenue for the three months ended in Dec. 2025 was $0.00 Mil. Therefore, Helus Pharma's pretax margin for the quarter that ended in Dec. 2025 was %.

The historical rank and industry rank for Helus Pharma's Pretax Margin % or its related term are showing as below:


HELP's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -90.5
* Ranked among companies with meaningful Pretax Margin % only.

Helus Pharma  (NAS:HELP) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Helus Pharma Pretax Margin % Related Terms

Helus Pharma Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Helus Pharma's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Helus Pharma Pretax Margin % Chart

Helus Pharma Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Pretax Margin %
Get a 7-Day Free Trial -3,731.73 0.00 0.00 0.00 0.00

Helus Pharma Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

HELP vs VRTX, REGN, ALNY: Pretax Margin % Comparison

For the Biotechnology subindustry, Helus Pharma's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Helus Pharma Pretax Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Helus Pharma's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Helus Pharma's Pretax Margin % falls into.


HELP
22GF Score
Helus Pharma Inc HELP
Pretax Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Helus Pharma Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Helus Pharma's Pretax Margin for the fiscal year that ended in Mar. 2025 is calculated as

Pretax Margin=Pre-Tax Income (A: Mar. 2025 )/Revenue (A: Mar. 2025 )
=-79.055/0
= %

Helus Pharma's Pretax Margin for the quarter that ended in Dec. 2025 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-42.668/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of % mean?
Helus Pharma (HELP) has a Pretax Margin % of % as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Helus Pharma and its competitors. According to the industry distribution chart, Helus Pharma ranks #999999 out of 944 companies in the Biotechnology industry.
Is Helus Pharma's Pretax Margin % too high?
Helus Pharma's current Pretax Margin % is %. Based on the distribution chart, Helus Pharma ranks #999999 out of 944 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Helus Pharma has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Helus Pharma's Pretax Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Helus Pharma ranks #999999 out of 944 companies for Pretax Margin %. This places Helus Pharma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Helus Pharma and its competitors. Helus Pharma's current Pretax Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Helus Pharma stock overvalued right now?
Helus Pharma (HELP) has a current Pretax Margin % of %. The current Pretax Margin % is %. Helus Pharma's overall GF Score™ is 22/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Helus Pharma (HELP), the current Pretax Margin % is % as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Helus Pharma Business Description

Other Exchanges R7E:GermanyHELP:Canada
Address 100 King Street West, Suite 5600, Toronto, ON, CAN, M5X 1C9
Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.
22GF Score

Get the complete analysis for HELP

Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.88
Price